Deloitte at the 2015 BIO International Convention

Creating synergies and developing relationships

The 2015 BIO International Convention is June 15-18 in Philadelphia, Pennsylvania.

Explore content

When executing an open innovation model, cooperation is key to competition

Biopharma companies’ reliance on a traditional, closed R&D model might stifle true innovation. However, companies that adopt a cooperative, open innovation framework are likely to spur product development, speed time to market, reduce costs, and increase competitiveness.

Download the PDF

Measuring the return from pharmaceutical innovation: Turning a corner?

The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.

Read the full report

Hear Deloitte speak

Join top thought leaders for a discussion on exciting new trends in translational medicine. Matthew Hudes, Principal and BioPharma Segment Leader, Deloitte Consulting LLP, will be taking part in a networking and panel breakfast session during BIO, “Translational Medicine: Accelerating Pipeline Success.” This session is hosted by the city of South San Francisco.


  • Ron Leuty, SF Business Times, Moderator
  • Matthew Hudes, Principal and BioPharma Segment Leader, Deloitte Consulting LLP
  • Martin Babler, CEO, Principia
  • Aarif Khakoo, site head, Amgen SSF
  • Melinda Richter, Executive Director, JLABS

Deloitte thinking on Translational Medicine:

Event details:

Date and time:

Wednesday, June 17, 2015
7:30 a.m. - 9:00 a.m.


Lowe’s Hotel
1200 Market Street
Rooms Washington A&B

Contact :

Leslie Arroyo 


Connect with key Deloitte Life Sciences leaders

Make the most of your BIO experience. Deloitte leaders representing areas including M&A, R&D, and innovation will be attending the 2015 BIO International Convention. If you would like to meet with one of them and discuss their views on key market forces shaping the industry and its future, please contact Rose Lee.

Join the conversation @DeloitteHealth

Follow @DeloitteHealth on Twitter to stay tuned in to the latest news and trends from the 2015 BIO International Convention and insights from Deloitte life sciences leaders. We want to hear from you about your BIO experience as well.

Join the conversation on @DeloitteHealth.